Calpastatin is regulated by protein never in mitosis gene A interacting-1 (PIN1) in endothelial cells

Biochemical and Biophysical Research Communications

Volumn 414, Issue 3, 2011, Pages 581-586

  Liu, Tongzheng ^a   Schneider, Ryan A ^b   Hoyt, Dale G ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF FINDLAY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Calpain; Calpastatin; Endothelial cells; PIN1

Indexed keywords

ALPHA TUBULIN; CALPAIN; CALPASTATIN; DOUBLE STRANDED RNA; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; NEVER IN MITOSIS GENE A INTERACTING 1 PROTEIN; PEPTIDYLPROLYL ISOMERASE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REGULATION; GENE SILENCING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANIMALS; CALCIUM-BINDING PROTEINS; CALPAIN; ENDOTHELIUM, VASCULAR; GENE KNOCKDOWN TECHNIQUES; MICE; MITOSIS; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; RNA, SMALL INTERFERING;

MURINAE;

EID: 80054942841     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.125     Document Type: Article

References (43)

1. Yaffe M.B., Schutkowski M., Shen M., Zhou X.Z., Stukenberg P.T., Rahfeld J.U., Xu J., Kuang J., Kirschner M.W., Fischer G., Cantley L.C., Lu K.P. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278:1957-1960.
2. Lu K.P., Zhou X.Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nature Reviews Molecular Cell Biology 2007, 8:904-916.
3. Ilsley J.L., Sudol M., Winder S.J. The WW domain: linking cell signalling to the membrane cytoskeleton. Cellular Signalling 2002, 14:183-189.
4. Lu K.P., Liou Y.C., Zhou X.Z. Pinning down proline-directed phosphorylation signaling. Trends in Cell Biology 2002, 12:164-172.
5. Ryo A., Suizu F., Yoshida Y., Perrem K., Liou Y.C., Wulf G., Rottapel R., Yamaoka S., Lu K.P. Regulation of NF-kappaB signaling by PIN1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Molecular Cell 2003, 12:1413-1426.
6. Finn G., Lu K.P. Phosphorylation-specific prolyl isomerase PIN1 as new diagnostic and therapeutic target for cancer. Current Cancer Drug Targets 2008, 8:223-229.
7. Monje P., Hernandez-Losa J., Lyons R.J., Castellone M.D., Gutkind J.S. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. Journal of Biological Chemistry 2005, 280:35081-35084.
8. Ryo A., Nakamura M., Wulf G., Liou Y.C., Lu K.P. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nature Cell Biology 2001, 3:793-801.
9. Yeh E.S., Means A.R. PIN1, the cell cycle and cancer. Nature Reviews Cancer 2007, 7:381-388.
10. Esnault S., Shen Z.J., Whitesel E., Malter J.S. The peptidyl-prolyl isomerase PIN1 regulates granulocyte-macrophage colony-stimulating factor mRNA stability in T lymphocytes. Journal of Immunology 2006, 177:6999-7006.
11. Pang R.W., Lee T.K., Man K., Poon R.T., Fan S.T., Kwong Y.L., Tse E. PIN1 expression contributes to hepatic carcinogenesis. Journal of Pathology 2006, 210:19-25.
12. Wulf G.M., Ryo A., Wulf G.G., Lee S.W., Niu T., Petkova V., Lu K.P. PIN1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO Journal 2001, 20:3459-3472.
13. Sultana R., Boyd-Kimball D., Poon H.F., Cai J., Pierce W.M., Klein J.B., Markesbery W.R., Zhou X.Z., Lu K.P., Butterfield D.A. Oxidative modification and down-regulation of PIN1 in Alzheimer's disease hippocampus: a redox proteomics analysis. Neurobiology of Aging 2006, 27:918-925.
14. Shen Z.J., Esnault S., Schinzel A., Borner C., Malter J.S. The peptidyl-prolyl isomerase PIN1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activation. Nature Immunology 2009, 10:257-265.
15. Liu T., Huang Y., Likhotvorik R.I., Keshvara L., Hoyt D.G. Protein never in mitosis gene A interacting-1 (PIN1) regulates degradation of inducible nitric oxide synthase in endothelial cells. American Journal of Physiology - Cell Physiology 2008, 295:C819-C827.
16. Liu T., Schneider R.A., Shah V., Huang Y., Likhotvorik R.I., Keshvara L., Hoyt D.G. Protein never in mitosis gene A interacting-1 regulates calpain activity and the degradation of cyclooxygenase-2 in endothelial cells. Journal of Inflammation (London) 2009, 6:20-28.
17. Mehendale H.M., Limaye P.B. Calpain: a death protein that mediates progression of liver injury. Trends in Pharmacological Sciences 2005, 26:232-236.
18. Li Y., Arnold J.M., Pampillo M., Babwah A.V., Peng T. Taurine prevents cardiomyocyte death by inhibiting NADPH oxidase-mediated calpain activation. Free Radical Biology and Medicine 2009, 46:51-61.
19. Yang H., Murthy S., Sarkar F.H., Sheng S., Reddy G.P., Dou Q.P. Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells. Journal of Cellular Physiology 2008, 217:569-576.
20. Saez M.E., Ramirez-Lorca R., Moron F.J., Ruiz A. The therapeutic potential of the calpain family: new aspects. Drug Discovery Today 2006, 11:917-923.
21. Sorimachi H., Suzuki K. The structure of calpain. Journal of Biochemistry 2001, 129:653-664.
22. Raveendran N.N., Silver K., Freeman L.C., Narvaez D., Weng K., Ganta S., Lillich J.D. Drug-induced alterations to gene and protein expression in intestinal epithelial cell 6 cells suggest a role for calpains in the gastrointestinal toxicity of nonsteroidal anti-inflammatory agents. Journal of Pharmacology and Experimental Therapeutics 2008, 325:389-399.
23. Vissing K., Overgaard K., Nedergaard A., Fredsted A., Schjerling P. Effects of concentric and repeated eccentric exercise on muscle damage and calpain-calpastatin gene expression in human skeletal muscle. European Journal of Applied Physiology 2008, 103:323-332.
24. Goll D.E., Thompson V.F., Li H., Wei W., Cong J. The calpain system. Physiological Reviews 2003, 83:731-801.
25. Melloni E., Michetti M., Salamino F., Minafra R., Pontremoli S. Modulation of the calpain autoproteolysis by calpastatin and phospholipids. Biochemical and Biophysical Research Communications 1996, 229:193-197.
26. Glading A., Bodnar R.J., Reynolds I.J., Shiraha H., Satish L., Potter D.A., Blair H.C., Wells A. Epidermal growth factor activates m-calpain (calpain II), in part, by at least extracellular signal-regulated kinase-mediated phosphorylation. Molecular and Cellular Biology 2004, 24:2499-2512.
27. Wendt A., Thompson V.F., Goll D.E. Interaction of calpastatin with calpain: a review. Biological Chemistry 2004, 385:465-472.
28. Shiraha H., Glading A., Chou J., Jia Z., Wells A. Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Molecular and Cellular Biology 2002, 22:2716-2727.
29. Salamino F., Averna M., Tedesco I., De Tullio R., Melloni E., Pontremoli S. Modulation of rat brain calpastatin efficiency by post-translational modifications. FEBS Letters 1997, 412:433-438.
30. Averna M., De Tullio R., Salamino F., Melloni E., Pontremoli S. Phosphorylation of rat brain calpastatins by protein kinase C. FEBS Letters 1999, 450:13-16.
31. Carragher N.O. Calpain inhibition: a therapeutic strategy targeting multiple disease states. Current Pharmaceutical Design 2006, 12:615-638.
32. Huang H., McIntosh J., Hoyt D. An efficient nonenzymatic method for isolation and culture of murine aortic endothelial cells and their response to inflammatory stimuli. In Vitro Cellular and Developmental Biology - Animal 2003, 39:43-50.
33. Niapour M., Yu Y., Berger S.A. Regulation of calpain activity by c-Myc through calpastatin and promotion of transformation in c-Myc-negative cells by calpastatin suppression. Journal of Biological Chemistry 2008, 283:21371-21381.
34. Rose J.L., Reeves K.C., Likhotvorik R.I., Hoyt D.G. Base excision repair proteins are required for integrin-mediated suppression of bleomycin-induced DNA breakage in murine lung endothelial cells. Journal of Pharmacology and Experimental Therapeutics 2007, 321:318-326.
35. Tompa P., Buzder-Lantos P., Tantos A., Farkas A., Szilagyi A., Banoczi Z., Hudecz F., Friedrich P. On the sequential determinants of calpain cleavage. Journal of Biological Chemistry 2004, 279:20775-20785.
36. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
37. Shackelford S.D., Koohmaraie M., Cundiff L.V., Gregory K.E., Rohrer G.A., Savell J.W. Heritabilities and phenotypic and genetic correlations for bovine postrigor calpastatin activity intramuscular fat content Warner-Bratzler shear force retail product yield and growth rate. Journal of Animal Science 1994, 72:857-863.
38. +activated protease possibly involved in myofibrillar protein turnover. Partial characterization of the purified enzyme. Biochemistry 1976, 15:2159-2167.
39. Snedecor G., Cochran W. Statistical Methods 1980, Iowa State University Press, Ames, IA.
40. Su Y., Cao W., Han Z., Block E.R. Cigarette smoke extract inhibits angiogenesis of pulmonary artery endothelial cells: the role of calpain. American Journal of Physiology Lung - Cellular and Molecular Physiology 2004, 287:L794-800.
41. Cui Z., Han Z., Li Z., Hu H., Patel J.M., Antony V., Block E.R., Su Y. Involvement of calpain-calpastatin in cigarette smoke-induced inhibition of lung endothelial nitric oxide synthase. American Journal of Respiratory Cell and Molecular Biology 2005, 33:513-520.
42. Adachi Y., Ishida-Takahashi A., Takahashi C., Takano E., Murachi T., Hatanaka M. Phosphorylation and subcellular distribution of calpastatin in human hematopoietic system cells. Journal of Biological Chemistry 1991, 266:3968-3972.
43. Melloni E., Averna M., Stifanese R., De Tullio R., Defranchi E., Salamino F., Pontremoli S. Association of calpastatin with inactive calpain: a novel mechanism to control the activation of the protease?. Journal of Biological Chemistry 2006, 281:24945-24954.